SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-22-032667
Filing Date
2022-02-09
Accepted
2022-02-09 16:07:52
Documents
145
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d130792d10k.htm   iXBRL 10-K 4526796
2 EX-10.23 d130792dex1023.htm EX-10.23 86948
3 EX-10.24 d130792dex1024.htm EX-10.24 7463
4 EX-10.25 d130792dex1025.htm EX-10.25 2751
5 EX-10.26 d130792dex1026.htm EX-10.26 3720
6 EX-21.1 d130792dex211.htm EX-21.1 6930
7 EX-23 d130792dex23.htm EX-23 1907
8 EX-31.1 d130792dex311.htm EX-31.1 10312
9 EX-31.2 d130792dex312.htm EX-31.2 10231
10 EX-32 d130792dex32.htm EX-32 4265
16 GRAPHIC g130792g24x64.jpg GRAPHIC 6737
17 GRAPHIC g130792g53y56.jpg GRAPHIC 6231
18 GRAPHIC g130792g73r68.jpg GRAPHIC 55534
  Complete submission text file 0001193125-22-032667.txt   19575776

Data Files

Seq Description Document Type Size
11 XBRL TAXONOMY EXTENSION SCHEMA teva-20211231.xsd EX-101.SCH 136695
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE teva-20211231_cal.xml EX-101.CAL 77052
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE teva-20211231_def.xml EX-101.DEF 820523
14 XBRL TAXONOMY EXTENSION LABEL LINKBASE teva-20211231_lab.xml EX-101.LAB 920959
15 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE teva-20211231_pre.xml EX-101.PRE 893726
139 EXTRACTED XBRL INSTANCE DOCUMENT d130792d10k_htm.xml XML 4086211
Mailing Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 5 BAZEL ST PO B 3190 PETACH TIKVA L3 49131
Business Address 5 BAZEL ST P O B 3190 PETACH TIKVA L3 49131 9729267267
TEVA PHARMACEUTICAL INDUSTRIES LTD (Filer) CIK: 0000818686 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-16174 | Film No.: 22607252
SIC: 2834 Pharmaceutical Preparations